Anusara Daenthanasanmak

发表

Ceramide synthesis regulates T cell activity and GVHD development.

H. Stark, B. Ogretmen, Yingjun Chang, 2017, JCI insight.

PIM‐2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity

S. Mehrotra, E. Hill, A. Kraft, 2018, The Journal of clinical investigation.

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation

C. von Kalle, A. Ganser, R. Blasczyk, 2015, Journal of Translational Medicine.

Targeting the Complement Alternative Pathway Permits Graft Versus Leukemia Activity while Preventing Graft Versus Host Disease

A. Alawieh, C. Atkinson, S. Tomlinson, 2020, Clinical Cancer Research.

Stabilization of Foxp3 by Targeting JAK2 Enhances Efficacy of CD8 Induced Regulatory T Cells in the Prevention of Graft-versus-Host Disease

Chen Liu, Hung D. Nguyen, D. Bastian, 2018, The Journal of Immunology.

Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells

Jinsam Chang, W. Suh, Fang-ping Chen, 2018, Front. Immunol..

Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse.

Hung D. Nguyen, D. Bastian, Yongxia Wu, 2019, Blood advances.

Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.

D. Fairlie, B. Ogretmen, C. Atkinson, 2018, JCI insight.

Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease.

S. Mehrotra, N. Maulik, B. Ogretmen, 2019, The Journal of clinical investigation.

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice.

S. Mehrotra, P. Chakraborty, Chen Liu, 2019, Blood.

Growing Bacteria Shed Elicitors of Drosophila Humoral Immunity

H. Steiner, Anusara Daenthanasanmak, J. Karlsson, 2011, Journal of Innate Immunity.

Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation

J. Singer, J. Pidala, C. Anasetti, 2018, Proceedings of the National Academy of Sciences.

Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma

T. Waldmann, M. Yoshioka, P. Green, 2022, Blood advances.

Dendritic Cell–Mediated Immune Humanization of Mice: Implications for Allogeneic and Xenogeneic Stem Cell Transplantation

A. Ganser, R. Stripecke, G. Salguero, 2014, The Journal of Immunology.

Enhanced efficacy of JAK1 inhibitor with mTORC1/C2 targeting in smoldering/chronic adult T cell leukemia

T. Waldmann, Meili Zhang, Craig J. Thomas, 2020, Translational oncology.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, Brian D. Kelly, 2016, Journal of Immunotherapy for Cancer.

Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

S. Mehrotra, E. Hill, A. Kraft, 2018, Clinical Cancer Research.

CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response.

G. Hardiman, K. Helke, M. Nishimura, 2018, Cell metabolism.

Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation.

H. Chi, S. Mehrotra, S. Chatterjee, 2016, The Journal of clinical investigation.

Engineered dendritic cells from cord blood and adult blood accelerate effector T cell immune reconstitution against HCMV

C. von Kalle, A. Ganser, B. Eiz-Vesper, 2015, Molecular therapy. Methods & clinical development.

A very long-acting IL-15: implications for the immunotherapy of cancer

John A. Hangasky, T. Waldmann, R. Reid, 2022, Journal for ImmunoTherapy of Cancer.

Targeting Host Complement C3a/C5a Receptors to Control of Acute Graft-Versus-Host Disease in Mice

D. Fairlie, S. Tomlinson, Chen Liu, 2015 .

EGR1 Addiction in Diffuse Large B-cell Lymphoma

T. Waldmann, L. Rui, C. Capitini, 2021, Molecular Cancer Research.

Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in Adult T-cell leukemia/lymphoma.

L. Staudt, T. Waldmann, T. Yokota, 2021, Blood.

Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo.

A. Schambach, A. Ganser, E. Weissinger, 2012, Vaccine.

Generation of lentivirus-induced dendritic cells under GMP-compliant conditions for adaptive immune reconstitution against cytomegalovirus after stem cell transplantation

C. von Kalle, A. Ganser, R. Blasczyk, 2015, Journal of Translational Medicine.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Charles J. Vaske, Rohan N. Borkar, David M. Schauder, 2016, Journal for ImmunoTherapy of Cancer.

Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells.

D. Fairlie, B. Ogretmen, C. Atkinson, 2018, JCI insight.